akash.verma@cenmed.com
(732) 447-1115-
FT2515-25GRStructure confirmed. Purity = 98%. Will ship with Certificate of Analysis (CoA) -
G656099-1mlGW806742X, an ATP mimetic and a potent MLKL (Mixed Lineage Kinase Domain-Like protein) inhibitor, binds the MLKL pseudokinase domain with a K d of 9.3 μM. GW806742X has activity against VEGFR2 ( IC 50 =2 nM). GW806742X retards MLKL membrane -
G650016-5mgGW806742X, an ATP mimetic and a potent MLKL (Mixed Lineage Kinase Domain-Like protein) inhibitor, binds the MLKL pseudokinase domain with a K d of 9.3 μM. GW806742X has activity against VEGFR2 ( IC 50 =2 nM). GW806742X retards MLKL membrane -
G650016-50mgGW806742X, an ATP mimetic and a potent MLKL (Mixed Lineage Kinase Domain-Like protein) inhibitor, binds the MLKL pseudokinase domain with a K d of 9.3 μM. GW806742X has activity against VEGFR2 ( IC 50 =2 nM). GW806742X retards MLKL membrane -
G650016-25mgGW806742X, an ATP mimetic and a potent MLKL (Mixed Lineage Kinase Domain-Like protein) inhibitor, binds the MLKL pseudokinase domain with a K d of 9.3 μM. GW806742X has activity against VEGFR2 ( IC 50 =2 nM). GW806742X retards MLKL membrane -
G650016-1mgGW806742X, an ATP mimetic and a potent MLKL (Mixed Lineage Kinase Domain-Like protein) inhibitor, binds the MLKL pseudokinase domain with a K d of 9.3 μM. GW806742X has activity against VEGFR2 ( IC 50 =2 nM). GW806742X retards MLKL membrane -
G650016-10mgGW806742X, an ATP mimetic and a potent MLKL (Mixed Lineage Kinase Domain-Like protein) inhibitor, binds the MLKL pseudokinase domain with a K d of 9.3 μM. GW806742X has activity against VEGFR2 ( IC 50 =2 nM). GW806742X retards MLKL membrane -
G650016-100mgGW806742X, an ATP mimetic and a potent MLKL (Mixed Lineage Kinase Domain-Like protein) inhibitor, binds the MLKL pseudokinase domain with a K d of 9.3 μM. GW806742X has activity against VEGFR2 ( IC 50 =2 nM). GW806742X retards MLKL membrane -
G648232-5mgGW438014A is a potent and selective NPY-Y5 receptor antagonist. GW438014A inhibits food intake and reduces body weight gain in obese rodents.In VivoGW438014A (10 mg/kg: i.p.: daily, for 7 d) inhibits spontaneous as well as overnight fasting-induced -
G648232-50mgGW438014A is a potent and selective NPY-Y5 receptor antagonist. GW438014A inhibits food intake and reduces body weight gain in obese rodents.In VivoGW438014A (10 mg/kg: i.p.: daily, for 7 d) inhibits spontaneous as well as overnight fasting-induced -
G648232-25mgGW438014A is a potent and selective NPY-Y5 receptor antagonist. GW438014A inhibits food intake and reduces body weight gain in obese rodents.In VivoGW438014A (10 mg/kg: i.p.: daily, for 7 d) inhibits spontaneous as well as overnight fasting-induced -
G648232-10mgGW438014A is a potent and selective NPY-Y5 receptor antagonist. GW438014A inhibits food intake and reduces body weight gain in obese rodents.In VivoGW438014A (10 mg/kg: i.p.: daily, for 7 d) inhibits spontaneous as well as overnight fasting-induced
